1. Home
  2. IGI vs ACOG Comparison

IGI vs ACOG Comparison

Compare IGI & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Defined Opportunity Trust Inc.

IGI

Western Asset Investment Grade Defined Opportunity Trust Inc.

HOLD

Current Price

$16.07

Market Cap

97.0M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$6.89

Market Cap

110.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IGI
ACOG
Founded
N/A
2000
Country
United States
Canada
Employees
N/A
57
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
97.0M
110.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
IGI
ACOG
Price
$16.07
$6.89
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
12.4K
76.2K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.78
$4.50
52 Week High
$17.09
$10.88

Technical Indicators

Market Signals
Indicator
IGI
ACOG
Relative Strength Index (RSI) 41.17 61.56
Support Level $15.78 $6.46
Resistance Level $16.59 $7.69
Average True Range (ATR) 0.14 0.54
MACD -0.01 0.04
Stochastic Oscillator 24.61 63.64

Price Performance

Historical Comparison
IGI
ACOG

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: